Skip to main content
NIH funding notice RFA-RM-22-005

Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed)

Closed on January 19, 2022.

Posted
October 28, 2021
Close date
January 19, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $950,000 in first-year total cost, median $475,000.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 CB-K (70)]2

Most frequent institutions

  1. BATTELLE PACIFIC NORTHWEST LABORATORIES1
  2. MAYO CLINIC ROCHESTER1
Competing awards under RFA-RM-22-005 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Spatially-resolved protein and transcriptome mapping of senescent cells1UG3CA275669-01SCHAFER, MARISSA JOYMAYO CLINIC ROCHESTER, MN$475,000ZRG1
2022Spatially-resolved proteome mapping of senescent cells and their tissue microenvironment at single-cell resolution1UG3CA275697-01PASA-TOLIC, LJILJANABATTELLE PACIFIC NORTHWEST LABORATORIES, WA$475,000ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.